NASDAQ:NOVT

Novanta Stock Forecast, Price & News

$139.85
-0.56 (-0.40 %)
(As of 08/2/2021 11:38 AM ET)
Add
Compare
Today's Range
$139.77
$142.87
50-Day Range
$126.38
$140.41
52-Week Range
$95.53
$146.16
Volume187 shs
Average Volume95,685 shs
Market Capitalization$4.95 billion
P/E Ratio113.70
Dividend YieldN/A
Beta0.99
30 days | 90 days | 365 days | Advanced Chart
Receive NOVT News and Ratings via Email

Sign-up to receive the latest news and ratings for Novanta and its competitors with MarketBeat's FREE daily newsletter.


Novanta logo

About Novanta

Novanta, Inc. engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products. The Vision segment offers a range of medical grade technologies, including medical insufflators, pumps and related disposables; surgical displays and operating room integration technologies; optical data collection and machine vision technologies; radio frequency identification technologies; thermal printers; spectrometry technologies; and embedded touch screen solutions. The Precision Motion segment includes optical encoders, precision motor and motion control technology, air bearing spindles, and precision machined components to customers. The company was founded in 1968 and is headquartered in Bedford, MA.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

2.06 out of 5 stars

Computer And Technology Sector

366th out of 1,646 stocks

Miscellaneous Electrical Machinery, Equipment, & Supplies Industry

7th out of 45 stocks

Analyst Opinion: 1.0Community Rank: 4.9Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Novanta (NASDAQ:NOVT) Frequently Asked Questions

Is Novanta a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Novanta in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Novanta stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NOVT, but not buy additional shares or sell existing shares.
View analyst ratings for Novanta
or view top-rated stocks.

What stocks does MarketBeat like better than Novanta?

Wall Street analysts have given Novanta a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Novanta wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Novanta's next earnings date?

Novanta is scheduled to release its next quarterly earnings announcement on Tuesday, August 10th 2021.
View our earnings forecast for Novanta
.

How can I listen to Novanta's earnings call?

Novanta will be holding an earnings conference call on Tuesday, August 10th at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Novanta's earnings last quarter?

Novanta Inc. (NASDAQ:NOVT) issued its quarterly earnings data on Tuesday, May, 11th. The technology company reported $0.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.19. The technology company had revenue of $162.60 million for the quarter, compared to the consensus estimate of $156.28 million. Novanta had a net margin of 7.34% and a trailing twelve-month return on equity of 15.66%. Novanta's revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period last year, the business posted $0.51 EPS.
View Novanta's earnings history
.

How has Novanta's stock been impacted by COVID-19 (Coronavirus)?

Novanta's stock was trading at $79.04 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, NOVT shares have increased by 76.9% and is now trading at $139.85.
View which stocks have been most impacted by COVID-19
.

What guidance has Novanta issued on next quarter's earnings?

Novanta updated its FY 2021 earnings guidance on Tuesday, June, 8th. The company provided earnings per share (EPS) guidance of $2.040-2.190 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.110. The company issued revenue guidance of $645 million-655 million, compared to the consensus revenue estimate of $644.35 million.

What price target have analysts set for NOVT?

1 Wall Street analysts have issued 12-month price objectives for Novanta's shares. Their forecasts range from $109.00 to $109.00. On average, they anticipate Novanta's stock price to reach $109.00 in the next year. This suggests that the stock has a possible downside of 22.1%.
View analysts' price targets for Novanta
or view top-rated stocks among Wall Street analysts.

Who are Novanta's key executives?

Novanta's management team includes the following people:
  • Matthijs Glastra, Chairman & Chief Executive Officer
  • Robert John Buckley, Chief Financial Officer
  • Sarah Betadam, Chief Information Officer
  • Peter Aka Lei Chang, Chief Accounting Officer, VP & Controller
  • Kitty Sahin, VP-Strategy & Business Development

What is Matthijs Glastra's approval rating as Novanta's CEO?

44 employees have rated Novanta CEO Matthijs Glastra on Glassdoor.com. Matthijs Glastra has an approval rating of 87% among Novanta's employees.

Who are some of Novanta's key competitors?

What other stocks do shareholders of Novanta own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Novanta investors own include NVIDIA (NVDA), Alibaba Group (BABA), Gilead Sciences (GILD), Intuitive Surgical (ISRG), Lam Research (LRCX), Altria Group (MO), AT&T (T), Abiomed (ABMD), Advanced Micro Devices (AMD) and Broadcom (AVGO).

What is Novanta's stock symbol?

Novanta trades on the NASDAQ under the ticker symbol "NOVT."

Who are Novanta's major shareholders?

Novanta's stock is owned by a variety of institutional and retail investors. Top institutional investors include Alliancebernstein L.P. (4.59%), Conestoga Capital Advisors LLC (3.16%), Ziegler Capital Management LLC (0.09%), Exchange Traded Concepts LLC (0.04%), Zurcher Kantonalbank Zurich Cantonalbank (0.01%) and Corbett Road Capital Management LLC (0.01%). Company insiders that own Novanta stock include Brian S Young, Matthijs Glastra, Peter L Chang, Robert Buckley and Stephen W Bershad.
View institutional ownership trends for Novanta
.

Which major investors are selling Novanta stock?

NOVT stock was sold by a variety of institutional investors in the last quarter, including Ziegler Capital Management LLC, Corbett Road Capital Management LLC, and Zurcher Kantonalbank Zurich Cantonalbank . Company insiders that have sold Novanta company stock in the last year include Brian S Young, Matthijs Glastra, Peter L Chang, and Robert Buckley.
View insider buying and selling activity for Novanta
or view top insider-selling stocks.

Which major investors are buying Novanta stock?

NOVT stock was bought by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., Conestoga Capital Advisors LLC, Tuttle Tactical Management, Exchange Traded Concepts LLC, and Cooper Financial Group.
View insider buying and selling activity for Novanta
or or view top insider-buying stocks.

How do I buy shares of Novanta?

Shares of NOVT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Novanta's stock price today?

One share of NOVT stock can currently be purchased for approximately $139.85.

How much money does Novanta make?

Novanta has a market capitalization of $4.95 billion and generates $590.62 million in revenue each year. The technology company earns $44.52 million in net income (profit) each year or $1.95 on an earnings per share basis.

How many employees does Novanta have?

Novanta employs 2,200 workers across the globe.

What is Novanta's official website?

The official website for Novanta is www.novanta.com.

Where are Novanta's headquarters?

Novanta is headquartered at 125 Middlesex Turnpike, Bedford MA, 01730.

How can I contact Novanta?

Novanta's mailing address is 125 Middlesex Turnpike, Bedford MA, 01730. The technology company can be reached via phone at (781) 266-5700 or via email at [email protected]


This page was last updated on 8/2/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.